Introduction
Atherosclerosis - Overview
Atherosclerosis - Therapeutics Development
Atherosclerosis - Therapeutics Assessment
Atherosclerosis - Companies Involved in Therapeutics Development
Atherosclerosis - Drug Profiles
Atherosclerosis - Dormant Projects
Atherosclerosis - Discontinued Products
Atherosclerosis - Product Development Milestonesh
Appendix

List of Tables
Number of Products under Development for Atherosclerosis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Atherosclerosis - Pipeline by Abcentra LLC, 2021
Atherosclerosis - Pipeline by ABIONYX Pharma SA, 2021
Atherosclerosis - Pipeline by Afimmune Biopharma Ltd, 2021
Atherosclerosis - Pipeline by Allysta Pharmaceuticals Inc, 2021
Atherosclerosis - Pipeline by Amgen Inc, 2021
Atherosclerosis - Pipeline by Annexin Pharmaceuticals AB, 2021
Atherosclerosis - Pipeline by AptaBio Therapeutics Inc, 2021
Atherosclerosis - Pipeline by Artery Therapeutics Inc, 2021
Atherosclerosis - Pipeline by Asdera LLC, 2021
Atherosclerosis - Pipeline by AstraZeneca Plc, 2021
Atherosclerosis - Pipeline by Athera Biotechnologies AB, 2021
Atherosclerosis - Pipeline by Auxagen Inc, 2021
Atherosclerosis - Pipeline by Band Therapeutics LLC, 2021
Atherosclerosis - Pipeline by BBN Cardio Therapeutics, 2021
Atherosclerosis - Pipeline by Boehringer Ingelheim International GmbH, 2021
Atherosclerosis - Pipeline by Centeer BioTherapeutics Ltd Co, 2021
Atherosclerosis - Pipeline by Civi Biopharma Inc, 2021
Atherosclerosis - Pipeline by CohBar Inc, 2021
Atherosclerosis - Pipeline by Daiichi Sankyo Co Ltd, 2021
Atherosclerosis - Pipeline by General Regeneratives Shanghai Ltd, 2021
Atherosclerosis - Pipeline by GenKyoTex SA, 2021
Atherosclerosis - Pipeline by Grindeks AS, 2021
Atherosclerosis - Pipeline by HCW Biologics Inc, 2021
Atherosclerosis - Pipeline by Innolife Co Ltd, 2021
Atherosclerosis - Pipeline by Inotrem SA, 2021
Atherosclerosis - Pipeline by Zehna Therapeutics LLC, 2021
Atherosclerosis - Dormant Projects, 2021
Atherosclerosis - Discontinued Products, 2021

List of Figures
Number of Products under Development for Atherosclerosis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021

Companies Mentioned
• Abcentra LLC
• ABIONYX Pharma SA
• Afimmune Biopharma Ltd
• Allysta Pharmaceuticals Inc
• Amgen Inc
• Annexin Pharmaceuticals AB
• AptaBio Therapeutics Inc
• Artery Therapeutics Inc
• Asdera LLC
• AstraZeneca Plc
• Athera Biotechnologies AB
• MetiMedi Pharmaceuticals Co Ltd
• MetrioPharm AG
• Novartis AG
• Novo Nordisk AS
• NuSirt Biopharma Inc
• Omeros Corp
• Pharmahungary Group
• PharmGen Science Inc
• Regeneron Pharmaceuticals Inc